A comparative study of LCZ696, valsartan and resveratrol for the treatment of acute cardiac remodeling and dysfunction in myocardial infarction induced rats

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Moderated Poster session 4 - Basic Science Treatment HFA Premium Access Heart Failure 2018

ESC 365 is supported by

ESC 365 is supported by